Dtsch Med Wochenschr 2008; 133(14): 721
DOI: 10.1055/s-2008-1067315
Pro & Contra | Commentary
Pneumologie
© Georg Thieme Verlag KG Stuttgart · New York

Die Therapie der pulmonal-arteriellen Hypertonie bei COPD ist sinnvoll - contra

The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - contraD. Köhler1
  • 1Fachkrankenhaus Kloster Grafschaft,Schmallenberg
Further Information

Publication History

Publication Date:
25 March 2008 (online)

Literatur

  • 1 Gassner A. et al . Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem and verapamil.  Chest. 1990;  98 829-34
  • 2 Rietema H. et al . Long-term effect of sildenafil on exercise capacity in COPD patients.  Eur Resp J. 2007;  30 A 3581
  • 3 Sliwinski, P. et al . Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease.  Am Rev Respir Dis. 1992;  146 665-669
  • 4 Stolz D. et al . Pulmonary vasodilator therapy in severe COPD: a double-blind, placebo-controlled trial.  Eur Resp J. 2007;  30 A 3164

Prof. Dr. Dieter Köhler

Fachkrankenhaus Kloster Grafschaft

57392 Schmallenberg

Phone: 02972/791-2501

Fax: 02972/791-2526

Email: d.koehler@fkkg.de